Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 26, 2017
Event: Announcement of financial results for the three and nine months ended September 30, 2017, and details of a related conference call.
Key Financial Metrics
This Form 8-K serves as a notification of a press release and does not contain specific financial data within the body of the filing. The document states that the press release (Exhibit 99.1) contains the details of the results but does not list specific values for revenue, profit, cash flow, margins, debt, or liquidity in this text. Therefore, the filing text does not provide a clear value for these metrics.
Material Changes
The filing does not disclose specific material changes versus prior periods. It references a press release for the announcement of results but does not summarize the comparative performance data within this document.
Guidance, Outlook, and Risks
Management Commentary: The company announced a conference call to be held at 4:30 PM EST on October 26, 2017, to discuss the results.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
Guidance/Risks: No specific guidance, outlook, risks, or contingencies are detailed in this filing text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the three and nine months ended September 30, 2017.
- Verify the details of the conference call held on October 26, 2017, for management commentary on the results.
- Confirm whether the press release includes updated forward-looking guidance or specific risk factors not present in this 8-K summary.
- Note that the financial data in the referenced press release is not legally "filed" under Section 18 of the Exchange Act per the disclaimer in this document.